As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

In genetic analysis, there are often competing explanations for the same data. Sophisticated mathematical models have been developed that can encapsulate these problems in terms of parameters that ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

The post How To Speed Up the Search for Cures Through a Change in Probability Theory appeared first on Reason.com.